An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: Hemophagocytic lymphohistiocytosis

Pediatric Critical Care Medicine

Volumn 10, Issue 3, 2009, Pages 285-290

  Karapinar, Bülent ^a   Yilmaz, Deniz ^a   Balkan, Can ^a   Akin, Mehmet ^a   Ay, Yilmaz ^a   Kvakli, Kaan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Children; Hemophagocytic lymphohistiocytosis; Multiple organ dysfunction syndrome; Pediatric intensive care unit; Sepsis

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN;

ADOLESCENT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW EXAMINATION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMA; CONTROLLED STUDY; CONVULSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROPHAGOCYTOSIS; FEMALE; HEART DISEASE; HEMODIALYSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HOSPITALIZATION; HUMAN; HYPOFIBRINOGENEMIA; INFANT; INFECTION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER DYSFUNCTION; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHOOL CHILD; SCORING SYSTEM; THROMBOCYTOPENIA; TREATMENT OUTCOME; LENGTH OF STAY; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 68849103040     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318198868b     Document Type: Article

References (39)

1. Henter JI, Elinder G, Soder O, et al: Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Pediatr Scand 1991; 80:428-435
2. Henter JI, Arico M, Elinder G, et al: Familial hemophagocytic lymphohistiocytosis: Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 417-433
3. Henter JI, Elinder G, Söder O, et al: Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78:2918-2922
4. Risdall RJ, McKenna RW, Nesbit ME, et al: Virus associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44:993-1002
5. Janka G, Imashuku S, Elinder G, et al: Infection- and malignancy- associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12:417-433
6. Henter JI, Arico M, Egeler RM: HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997; 28:342-347
7. Mischler M, Fleming MG, Shanley TP, et al: Epstein- Barr virus- induced hemophagocytic lymhohistiocytosis and X- linked lymphoproliferative disease: Mimicking of sepsis in the pediatric intensive care unit. Pediatrics 2007; 119:1212-1218
8. Henter JI, Horne AC, Arico M, et al; for the Histiocyte Society: HLH 2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124-131
9. Verbsky J, Grossman WJ: Hemophagocytic lymhohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006; 38:20-31
10. Ueda I, Ishii E, Morimoto A, et al: Correlation between phenotypic heterogeneity and gene mutational characteristics in familial Hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 2006; 46:482-488
11. Kogawa K, Lee SM, Villanueva J, et al: Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymhohistiocytosis and their family members. Blood 2002; 99:61-66
12. Janka G, Imashuku S, Elinder G, et al: Infection- and malignancy associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12:435-444
13. Chen RL, Lin KH, Lin DT, et al: Immuno-modulation treatment for childhood virus associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 89:282-290
14. Nahum EI, Ben-Ari J, Stain J, et al: Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure. Pediatr Crit Care Med 2000; 1:51-54
15. Gauvin F, Toledano B, Champagne J, et al: Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 2000; 28: 3341-3345
16. DiCarlo J, Lui WYS, Frankel L, et al: The hemophagocytic syndrome: Titrating continuous hemofiltration to the degree of lactic acidosis. Pediatr Hematol Oncol 2006; 23: 599-610
17. Rooms L, Fitzgerald N, McClain KL: Hemophagocytic lymphohistiocytosis masquerading as child abuse: Presentation of three cases and review of central nervous system findings in hemophagocytic lymphohistiocytosis. Pediatrics 2003; 111:636-640
18. Leteurtre S, Martinot A, Duhamel A, et al: Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet 2003; 362:192-197
19. Janka G, zur Stadt U: Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005: 82-88
20. Sung L, Weitzman S, Petric M, et al: The role of infections in primary hemophagocytic lymphohistiocytosis: A case series and review of the literature. Clin Infect Dis 2001; 33: 1644-1648
21. Gurgey A, Gögüçs S, Özyürek E, et al: Primary hemophagocytic lymhohistiocytosis in Turkish children. Pediatr Hematol Oncol 2003; 20:367-371
22. Proulx F, Fayon M, Farrel CA, et al: Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996; 109:1033-1037
23. Wilkinson JD, Pollack MM, Ruttimann UE, et al: Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14:271-274
24. Wilkinson JD, Pollack MM, Glass NL, et al: Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 1987; 111:324-328
25. Proulx F, Gauthier M, Nadeau D, et al: Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 1994; 22:1025-1031
26. Arico M, Imashuku S, Clementi R, et al: Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative dçssease gene. Blood 2001; 97:1131-1133
27. Ward DM, Shiflett SL, Kaplan J: Chediak Higashi syndrome: A clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002; 2:468-477
28. Bizario JC, Feldman J, Castro FA, et al: Griscelli syndrome: Characterization of a new mutation and rescue of cytotoxic activity by retroviral transfer of RAB27Agene. J Clin Immunol 2004; 24:397-410
29. Duval M, Fenneteau O, Doireau V, et al: Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 1999; 134:236-239
30. Fitzgerald NE, McClain KL: Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 2003; 33:392-401
31. Henter JI, Nennesmo I: Neuropathological findings and neurological symptoms in 23 children with hemophagocytic lymphohistiocytosis. Pediatrics 1997; 130:358-365
32. Haddad E, Sulis ML, Jabado N, et al: Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997; 89:794-800
33. Forbes KPN, Collie DA, Parker A: CNS involvement of virus-associated hemophagocytic syndrome: MR imaging appearance. AJNR Am J Neuroradiol 2000; 21:1248-1250
34. Chen CJ, Huang YC, Jaing TH, et al: Hemophagocytic syndrome: A review of 18 pediatric cases. J Microbiol Immunol Infect 2004; 37:157-163
35. Janka GE: Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-230
36. Ishii E, Ueda I, Shirakawa R, et al: Genetic subtypes of familial hemophagocytic lymphohistiocytosis: Correlations with clinical features and cytotoxic T lymphocyte/natural killer call functions. Blood 2005; 105: 3442-3448
37. Imashuku S, Hibi S, Ohara T, et al: Effective control of Epstein-Barr virus-related Hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869-1874
38. Verbsky JW, White AJ: Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 2004; 31:2071-2075
39. Makay M, Yilmaz S, Türkyilmaz Z, et al: Etanercept for therapy-resistant macrophage activation syndrome. Pediatr Blood Cancer 2008; 50:419-421